Skip to main content

Table 3 Comparison of gene mutation related to prognosis of APL patients with and without thrombosis

From: Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia

Gene mutations APL patients with thrombosis(7) APL patients without thrombosis(37) P values
WT-1 5 (71.4%) 9 (24.3%) 0.01
FLT3-ITD 6 (85.7%) 8 (21.6%) 0.0008
DNMT3A 0 (0%) 3 (8.1%) 0.44
TET2 2 (28.6%) 6 (16.2%) 0.43
IDH1 1 (14.3%) 3 (8.1%) 0.6
IDH2 0 (0%) 1 (2.7%) 0.66
NRAS 0 (0%) 1 (2.7%) 0.66
ASXL1 1 (14.3%) 6 (16.2%) 0.9
TP53 0 (0%) 0 (0%)
RUNX1 0 (0%) 0 (0%)
NPM1 0 (0%) 0 (0%)
CEBPA 0 (0%) 0 (0%)
C-kit 0 (0%) 0 (0%)
dupMLL 0 (0%) 0 (0%)